Empagliflozin in Type 1 Diabetes

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - New Zealand
doi 10.2147/dmso.s194688
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited